Karyopharm Therapeutics Inc. Earnings Per Share (Basic)
Karyopharm Therapeutics Inc. (KPTI) reported Earnings Per Share (Basic) of -$2.32 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- Karyopharm Therapeutics Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$2.32.
- Karyopharm Therapeutics Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$1.02.
- Karyopharm Therapeutics Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$3.82.
- Karyopharm Therapeutics Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$4.32, a 291.15% decline year-over-year.
- Karyopharm Therapeutics Inc. earnings per share, basic for fiscal 2025 was -$17.93.
- Karyopharm Therapeutics Inc. earnings per share, basic for fiscal 2024 was -$9.41.
- Karyopharm Therapeutics Inc. earnings per share, basic for fiscal 2023 was -$18.79.
- Karyopharm Therapeutics Inc. earnings per share, basic for fiscal 2022 was -$2.02.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.32 10-Q · filed 2026-08-13 | -$3.51 10-Q · filed 2026-08-13 | ||||||
| 2026-03-31 | -$1.02 10-Q · filed 2026-05-14 | |||||||
| 2025-12-31 | -$17.93 10-K · filed 2026-02-13 | |||||||
| 2025-09-30 | -$3.82 10-Q · filed 2025-11-03 | -$10.93 10-Q · filed 2025-11-03 | ||||||
| 2025-06-30 | -$4.32 10-Q · filed 2026-08-13 | -$7.11 10-Q · filed 2026-08-13 | ||||||
| 2025-03-31 | -$2.77 10-Q · filed 2026-05-14 | |||||||
| 2024-12-31 | -$9.41 10-K · filed 2026-02-13 | -$0.63 10-K · filed 2025-02-19 | ||||||
| 2024-09-30 | -$3.85 10-Q · filed 2025-11-03 | -$0.26 10-Q · filed 2024-11-05 | -$5.68 10-Q · filed 2025-11-03 | -$0.38 10-Q · filed 2024-11-05 | ||||
| 2024-06-30 | $2.26 10-Q · filed 2025-08-11 | $0.15 10-Q · filed 2024-08-06 | -$1.72 10-Q · filed 2025-08-11 | -$0.11 10-Q · filed 2024-08-06 | ||||
| 2024-03-31 | -$4.85 10-Q · filed 2025-05-12 | -$0.32 10-Q · filed 2024-05-08 | ||||||
| 2023-12-31 | -$18.79 10-K · filed 2026-02-13 | -$1.25 10-K · filed 2024-02-29 | ||||||
| 2023-09-30 | -$0.30 10-Q · filed 2024-11-05 | -$0.89 10-Q · filed 2024-11-05 | ||||||
| 2023-06-30 | -$0.29 10-Q · filed 2024-08-06 | -$0.59 10-Q · filed 2024-08-06 | ||||||
| 2023-03-31 | -$0.30 10-Q · filed 2024-05-08 | |||||||
| 2022-12-31 | -$2.02 10-K · filed 2025-02-19 | |||||||
| 2022-09-30 | -$0.45 10-Q · filed 2023-11-02 | -$1.60 10-Q · filed 2023-11-02 | ||||||
| 2022-06-30 | -$0.62 10-Q · filed 2023-08-02 | -$1.15 10-Q · filed 2023-08-02 | ||||||
| 2022-03-31 | -$0.53 10-Q · filed 2023-05-04 | |||||||
| 2021-12-31 | -$1.65 10-K · filed 2024-02-29 | |||||||
| 2021-09-30 | -$0.69 10-Q · filed 2022-11-03 | -$2.17 10-Q · filed 2022-11-03 | ||||||
| 2021-06-30 | -$0.71 10-Q · filed 2022-08-04 | -$1.48 10-Q · filed 2022-08-04 | ||||||
| 2020-12-31 | -$2.72 10-K · filed 2023-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |